Frontline is trading at $50.09, down 4.44%, with no verified company-specific catalyst identified for November 4, 2026.
- A report attributed Frontline’s November 2 decline to easing U.S.–Iran tensions and lower tanker risk premiums, but did not establish the cause of today’s move.
- Supplied broad-market indicators are sharply positive and do not explain Frontline’s decline; available evidence leaves today’s catalyst unclear.